Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine

This publication has 47 references indexed in Scilit:

• Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers
  The American Journal of Tropical Medicine and Hygiene, 2009
• Targeted Mutagenesis as a Rational Approach to Dengue Virus Vaccine Development
  Published by Springer Nature ,2009
• Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4
  Vaccine, 2007
• Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys
  Vaccine, 2003
• Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells
  Vaccine, 2003
• Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes
  Journal of Virology, 2002
• Differential Susceptibility ofAedes aegyptito Infection by the American and Southeast Asian Genotypes of Dengue Type 2 Virus
  Vector-Borne and Zoonotic Diseases, 2001
• Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
  Vaccine, 2001
• Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
  The Journal of Infectious Diseases, 2000
• Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks
  Archives of internal medicine (1960), 1991